Tag: clinical phase 2 trial

Aquestive's AQST-109

Anaphylm™, Aquestive’s Needleless Sublingual Epinephrine, Takes Another Step Forward

Company reports positive topline results from phase 2 study.
Aravax

Aravax Doses First Patient in Phase 2 Peanut Allergy Clinical Trial 

PVX108 does not contain peanut proteins which put patients at risk of serious side effects.
Revolo Biotherapeutics '1104

Peptide Shows Promise as an Allergen-Agnostic Treatment for Food Allergy

Revolog presents new data demonstrating long-lasting effect of '1104 candidate.
SLIT

Novel Peanut Allergy Treatment Shown to be Safe, Effective, and Lasting

A unique peanut allergy immunotherapy continues to show promise for children.
Boiled Peanuts

Study of Boiled Peanuts Show Promise for Treatment of Peanut Allergy

OIT with boiled followed by roasted peanuts appears effective with a favorable safety profile.
Aquestive AQST-109 Epinephrine Film

Aquestive Receives Positive FDA Response to Epinephrine Sublingual Film Phase 2...

Response confirms approach and supports the characterization of their novel drug platform.
Aquestive's AQST-109

Aquestive’s Sublingual Emergency Epinephrine Compares Favorably to EpiPen® in EPIPHAST II...

The company announced topline results from their EPIPHAST II study.
Baby

Siolta Begins Phase 2 Study in Newborns of Bacteria Consortia ...

STMC-103H has a combination of bacteria that are depleted in the gut microbiota of infants who go on to develop allergic sensitization and allergic diseases in childhood.
Aquestive AQST-109 Epinephrine Film

Aquestive Reports Positive Results from Sublingual Epinephrine Clinical Trial

Phase 2 study continues to show AQST-109 is safe and well tolerated.